Glioblastoma Study Shows Promising Results with Resveratrol and Copper Supplements
Glioblastoma is a highly aggressive form of cancer, but a recent study testing the effects of resveratrol and copper supplements on glioblastoma tumors has shown encouraging results, potentially opening up new avenues for treatment.
Resveratrol and copper are both nutraceuticals, derived from plants or food sources and believed to have health benefits. In a study conducted at Tata Memorial Hospital in India, glioblastoma patients undergoing surgery were given tablets containing both resveratrol and copper.
Comparing the brain tumor samples of the patients who received the supplements to those of a control group who did not, researchers found promising preliminary results. While no visible changes in tumor size or aggressiveness were observed, markers of cancer growth were reduced in the treated group.
Furthermore, levels of proteins that suppress immune responses to cancer were lower in the treated group, as were biomarkers for stem cells that contribute to cancer growth.
The study, which is ongoing and aims to recruit 66 patients in total, will continue to monitor the patients’ progress over the next two years to determine the long-term effects of the supplements on survival rates.
Previous research by the team has shown that resveratrol and copper can target and deactivate cell-free chromatin particles, which can damage DNA and exacerbate cancer aggressiveness. By reducing these particles in the brain, the supplements may help to subdue the cancer.
With glioblastoma having poor survival rates, the study’s findings offer a new perspective on cancer treatment, focusing on healing tumors rather than simply destroying them with traditional methods like chemotherapy and radiotherapy.
While the results are promising, further research is needed to fully understand the potential of resveratrol and copper supplements in treating glioblastoma. The study has been published in BJC Reports.
